Figure 1: Neuroimaging of two patients with idiopathic normal pressure hydrocephalus. Because INPH is a disease of the elderly population, an age-group in which gait difficulties, dementia ...
CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients with normal pressure hydrocephalus (NPH). At the 90-day primary endpoint of ...
CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback